This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Jean M Lewis in Biomarker Analysis
Introduction
Jean M Lewis is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of biomarker analysis through his innovative patent. His work focuses on the development of miniaturized electronic systems that enhance the efficiency of biomarker analysis.
Latest Patents
One of Jean M Lewis's notable patents is titled "Electrokinetic microelectrode devices and methods for biomarker analysis." This patent discloses miniaturized electronic systems, devices, and methods that can be incorporated into blood collection tubes and other containers. These innovations enable the immediate isolation, concentration, analysis, and storage of disease-related biomarkers upon blood draw. The miniaturized electronic system includes a high-surface area folded or sandwiched electrokinetic microelectrode array chip device. This device allows both AC dielectrophoretic (DEP) and DC electrophoretic-based separation and isolation processes to be used for the concentration of biomarkers.
Career Highlights
Throughout his career, Jean M Lewis has demonstrated a commitment to advancing technology in the medical field. His innovative approaches have the potential to revolutionize how biomarkers are analyzed and utilized in clinical settings. With a focus on practical applications, his work addresses critical needs in disease detection and management.
Collaborations
Jean M Lewis has collaborated with notable individuals in his field, including Michael J Heller and Daniel Heineck. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Jean M Lewis's contributions to biomarker analysis through his patent highlight the importance of innovation in medical technology. His work not only enhances the efficiency of biomarker analysis but also paves the way for future advancements in disease detection and management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
